Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Chronic | 19 | 2024 | 289 | 8.820 |
Why?
|
Pancreatitis | 25 | 2024 | 1096 | 8.530 |
Why?
|
Pancreatic Function Tests | 5 | 2017 | 69 | 2.210 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2024 | 86 | 1.650 |
Why?
|
Acute Disease | 22 | 2024 | 7237 | 1.630 |
Why?
|
Secretin | 3 | 2017 | 57 | 1.590 |
Why?
|
Pancreatitis, Alcoholic | 2 | 2022 | 28 | 1.550 |
Why?
|
Endoscopy, Gastrointestinal | 17 | 2024 | 874 | 1.340 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 11 | 2024 | 506 | 1.260 |
Why?
|
Colonoscopy | 7 | 2022 | 1394 | 1.230 |
Why?
|
Alcoholism | 4 | 2022 | 1973 | 1.210 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2022 | 625 | 1.140 |
Why?
|
Endosonography | 6 | 2024 | 609 | 1.130 |
Why?
|
Lipase | 2 | 2021 | 325 | 1.100 |
Why?
|
Gallstones | 3 | 2022 | 284 | 0.990 |
Why?
|
Pancreas | 5 | 2023 | 1691 | 0.980 |
Why?
|
Gastroenterology | 6 | 2016 | 577 | 0.840 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5368 | 0.820 |
Why?
|
Choledocholithiasis | 1 | 2022 | 49 | 0.780 |
Why?
|
Adenoma | 5 | 2022 | 2160 | 0.770 |
Why?
|
Colonic Polyps | 5 | 2022 | 554 | 0.750 |
Why?
|
Patient Discharge | 2 | 2024 | 3443 | 0.700 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2023 | 357 | 0.700 |
Why?
|
Cholestasis | 6 | 2024 | 378 | 0.650 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 409 | 0.650 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 422 | 0.630 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 233 | 0.630 |
Why?
|
Pancreatic Juice | 1 | 2017 | 60 | 0.570 |
Why?
|
Critical Pathways | 2 | 2018 | 474 | 0.570 |
Why?
|
Bicarbonates | 1 | 2017 | 292 | 0.540 |
Why?
|
Opioid-Related Disorders | 2 | 2022 | 2164 | 0.520 |
Why?
|
Quality Indicators, Health Care | 3 | 2023 | 1792 | 0.520 |
Why?
|
Analgesics, Opioid | 7 | 2022 | 3808 | 0.510 |
Why?
|
Colorectal Neoplasms | 5 | 2022 | 6935 | 0.510 |
Why?
|
Thrombectomy | 3 | 2024 | 705 | 0.500 |
Why?
|
Publications | 1 | 2017 | 194 | 0.470 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1117 | 0.460 |
Why?
|
Watchful Waiting | 1 | 2018 | 491 | 0.460 |
Why?
|
Hypertension, Portal | 4 | 1996 | 226 | 0.450 |
Why?
|
Humans | 116 | 2024 | 761504 | 0.450 |
Why?
|
Length of Stay | 6 | 2023 | 6425 | 0.440 |
Why?
|
Peer Review, Research | 1 | 2017 | 340 | 0.440 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1727 | 0.430 |
Why?
|
Osteoporosis | 1 | 2023 | 1606 | 0.430 |
Why?
|
Clinical Competence | 5 | 2020 | 4792 | 0.420 |
Why?
|
Pilot Projects | 7 | 2023 | 8631 | 0.400 |
Why?
|
Curriculum | 8 | 2021 | 3743 | 0.400 |
Why?
|
Retrospective Studies | 23 | 2024 | 80636 | 0.390 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2016 | 450 | 0.380 |
Why?
|
Hospitalization | 6 | 2024 | 10723 | 0.370 |
Why?
|
Fractures, Bone | 1 | 2023 | 2046 | 0.360 |
Why?
|
Endovascular Procedures | 4 | 2024 | 2183 | 0.350 |
Why?
|
Emergency Service, Hospital | 4 | 2024 | 7879 | 0.310 |
Why?
|
Patient Readmission | 4 | 2024 | 3270 | 0.300 |
Why?
|
Stents | 7 | 2024 | 3179 | 0.300 |
Why?
|
Cholecystectomy | 2 | 2020 | 406 | 0.300 |
Why?
|
Hospitals | 1 | 2020 | 3882 | 0.280 |
Why?
|
Hepatitis, Chronic | 1 | 2006 | 52 | 0.280 |
Why?
|
Middle Aged | 42 | 2024 | 220895 | 0.280 |
Why?
|
Cholangitis, Sclerosing | 2 | 2011 | 177 | 0.270 |
Why?
|
Drainage | 2 | 2024 | 1157 | 0.270 |
Why?
|
Risk Factors | 16 | 2024 | 74206 | 0.270 |
Why?
|
Critical Illness | 2 | 2017 | 2723 | 0.260 |
Why?
|
Male | 55 | 2024 | 360804 | 0.260 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1463 | 0.250 |
Why?
|
Biliary Tract Diseases | 2 | 2024 | 159 | 0.250 |
Why?
|
Female | 49 | 2024 | 392644 | 0.250 |
Why?
|
Adult | 41 | 2024 | 221177 | 0.240 |
Why?
|
Intracranial Aneurysm | 2 | 2024 | 1285 | 0.230 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 597 | 0.230 |
Why?
|
Practice Guidelines as Topic | 7 | 2019 | 7390 | 0.230 |
Why?
|
Diagnostic Imaging | 2 | 2015 | 3530 | 0.220 |
Why?
|
Liver Cirrhosis | 3 | 2006 | 1935 | 0.220 |
Why?
|
Review Literature as Topic | 2 | 2023 | 348 | 0.220 |
Why?
|
Pancreatic Hormones | 1 | 2022 | 12 | 0.210 |
Why?
|
Abdominal Pain | 2 | 2023 | 1071 | 0.210 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1654 | 0.210 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1459 | 0.210 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2002 | 44 | 0.210 |
Why?
|
Chloride Channels | 2 | 2004 | 221 | 0.210 |
Why?
|
Fluid Therapy | 2 | 2024 | 579 | 0.210 |
Why?
|
Constriction, Pathologic | 5 | 2024 | 1096 | 0.210 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.200 |
Why?
|
Time Factors | 12 | 2024 | 39967 | 0.200 |
Why?
|
Celiac Disease | 4 | 2011 | 821 | 0.200 |
Why?
|
Recurrence | 5 | 2022 | 8465 | 0.200 |
Why?
|
Gastric Balloon | 1 | 2022 | 36 | 0.200 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2022 | 116 | 0.200 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15842 | 0.190 |
Why?
|
Aged | 27 | 2024 | 169289 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2023 | 2330 | 0.180 |
Why?
|
Acetylation | 1 | 2023 | 1055 | 0.180 |
Why?
|
Nerve Block | 2 | 2024 | 706 | 0.180 |
Why?
|
Helicobacter pylori | 3 | 2009 | 377 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.180 |
Why?
|
Chlorides | 1 | 2003 | 665 | 0.180 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 15266 | 0.170 |
Why?
|
Prescriptions | 1 | 2022 | 386 | 0.170 |
Why?
|
Inpatients | 2 | 2022 | 2548 | 0.170 |
Why?
|
Lung Diseases, Obstructive | 1 | 2001 | 308 | 0.170 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1386 | 0.170 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 94 | 0.170 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1702 | 0.170 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2021 | 119 | 0.160 |
Why?
|
Early Diagnosis | 2 | 2015 | 1186 | 0.160 |
Why?
|
Pain, Postoperative | 2 | 2022 | 1739 | 0.160 |
Why?
|
Gallbladder Neoplasms | 1 | 2000 | 189 | 0.160 |
Why?
|
Preventive Medicine | 1 | 2000 | 246 | 0.160 |
Why?
|
Megacolon, Toxic | 1 | 1998 | 8 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12148 | 0.150 |
Why?
|
Prospective Studies | 13 | 2020 | 54425 | 0.150 |
Why?
|
Collateral Circulation | 2 | 1996 | 294 | 0.150 |
Why?
|
Quality of Life | 4 | 2024 | 13367 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.150 |
Why?
|
Duodenum | 3 | 2017 | 490 | 0.150 |
Why?
|
Encephalitozoonosis | 1 | 1997 | 2 | 0.150 |
Why?
|
Thromboembolism | 1 | 2024 | 995 | 0.150 |
Why?
|
Encephalitozoon | 1 | 1997 | 5 | 0.140 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2017 | 45 | 0.140 |
Why?
|
Bile Ducts | 2 | 2011 | 282 | 0.140 |
Why?
|
Pain | 2 | 2022 | 5073 | 0.140 |
Why?
|
Feasibility Studies | 2 | 2018 | 5247 | 0.140 |
Why?
|
Portal System | 1 | 1996 | 49 | 0.140 |
Why?
|
Conflict of Interest | 4 | 2014 | 554 | 0.140 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1996 | 63 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2023 | 2273 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39106 | 0.130 |
Why?
|
Endoscopy | 4 | 2021 | 1851 | 0.130 |
Why?
|
Aspartate Aminotransferases | 1 | 1998 | 416 | 0.130 |
Why?
|
Hepatic Encephalopathy | 1 | 1997 | 144 | 0.130 |
Why?
|
Glycoproteins | 1 | 2023 | 2203 | 0.130 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6346 | 0.130 |
Why?
|
Body Fluids | 1 | 2017 | 320 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1974 | 0.130 |
Why?
|
United States | 11 | 2023 | 72334 | 0.130 |
Why?
|
Diazinon | 1 | 1995 | 4 | 0.120 |
Why?
|
Capnography | 1 | 2016 | 91 | 0.120 |
Why?
|
Splenomegaly | 1 | 1996 | 189 | 0.120 |
Why?
|
Smoking | 2 | 2023 | 9053 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 1998 | 603 | 0.120 |
Why?
|
Hepatitis | 1 | 1997 | 228 | 0.120 |
Why?
|
Societies, Medical | 5 | 2024 | 3905 | 0.120 |
Why?
|
Celiac Plexus | 2 | 2024 | 32 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 343 | 0.120 |
Why?
|
Massachusetts | 3 | 2024 | 8830 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2009 | 388 | 0.120 |
Why?
|
Colonic Diseases | 1 | 2016 | 201 | 0.120 |
Why?
|
Midazolam | 1 | 2016 | 266 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2006 | 2298 | 0.110 |
Why?
|
Counseling | 1 | 2022 | 1547 | 0.110 |
Why?
|
Paralysis | 1 | 1995 | 250 | 0.110 |
Why?
|
Insecticides | 1 | 1995 | 191 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 662 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3688 | 0.110 |
Why?
|
Treatment Outcome | 15 | 2024 | 64680 | 0.110 |
Why?
|
Cystic Fibrosis | 3 | 2016 | 1285 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12059 | 0.110 |
Why?
|
Cholinesterase Inhibitors | 1 | 1995 | 242 | 0.110 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14666 | 0.110 |
Why?
|
Nose | 1 | 2016 | 521 | 0.100 |
Why?
|
Bronchial Diseases | 1 | 2014 | 150 | 0.100 |
Why?
|
Fentanyl | 1 | 2016 | 434 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2017 | 510 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 851 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 1200 | 0.100 |
Why?
|
Pain Measurement | 2 | 2020 | 3550 | 0.100 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2751 | 0.100 |
Why?
|
Pesticides | 1 | 1995 | 296 | 0.100 |
Why?
|
Gastric Mucosa | 2 | 2021 | 604 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 299 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.100 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 509 | 0.100 |
Why?
|
Pneumothorax | 1 | 1995 | 385 | 0.100 |
Why?
|
Pulmonary Medicine | 1 | 2014 | 221 | 0.100 |
Why?
|
Conscious Sedation | 1 | 2016 | 532 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2078 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2022 | 1277 | 0.090 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4320 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2015 | 811 | 0.090 |
Why?
|
Blood Coagulation | 1 | 1996 | 1154 | 0.090 |
Why?
|
Air | 1 | 2010 | 187 | 0.090 |
Why?
|
Mesalamine | 1 | 2011 | 135 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58976 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 263 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 636 | 0.080 |
Why?
|
Bone Density | 1 | 2023 | 3551 | 0.080 |
Why?
|
Benchmarking | 1 | 2016 | 1045 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2021 | 22176 | 0.080 |
Why?
|
Hepatitis C, Chronic | 1 | 1998 | 1032 | 0.080 |
Why?
|
Rectal Diseases | 1 | 2010 | 143 | 0.080 |
Why?
|
Age Factors | 3 | 2024 | 18395 | 0.080 |
Why?
|
Colon | 3 | 2010 | 1792 | 0.080 |
Why?
|
Prognosis | 4 | 2023 | 29625 | 0.080 |
Why?
|
Incidence | 4 | 2021 | 21353 | 0.080 |
Why?
|
Spleen | 1 | 1995 | 2295 | 0.080 |
Why?
|
Endoscopy, Digestive System | 2 | 2023 | 351 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.080 |
Why?
|
Critical Care | 1 | 2001 | 2696 | 0.080 |
Why?
|
Patient Care | 1 | 2013 | 622 | 0.070 |
Why?
|
Insulin | 1 | 2022 | 6596 | 0.070 |
Why?
|
Internal Medicine | 1 | 2015 | 1051 | 0.070 |
Why?
|
Resuscitation | 2 | 2024 | 673 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.070 |
Why?
|
Cholangiocarcinoma | 2 | 2023 | 552 | 0.070 |
Why?
|
Urease | 1 | 2007 | 39 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 455 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 277 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3358 | 0.070 |
Why?
|
Docosahexaenoic Acids | 2 | 2011 | 908 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10773 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2017 | 20098 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 330 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 1996 | 2651 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.070 |
Why?
|
Phototherapy | 1 | 2009 | 368 | 0.070 |
Why?
|
Bone Marrow | 1 | 1996 | 2911 | 0.060 |
Why?
|
Sleep | 1 | 2022 | 4768 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5336 | 0.060 |
Why?
|
Internship and Residency | 3 | 2021 | 5880 | 0.060 |
Why?
|
Breath Tests | 1 | 2007 | 299 | 0.060 |
Why?
|
Patient Care Team | 1 | 2017 | 2521 | 0.060 |
Why?
|
Liver | 3 | 2011 | 7529 | 0.060 |
Why?
|
Choledochostomy | 1 | 2024 | 16 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 12974 | 0.060 |
Why?
|
Ultrasonography | 5 | 2020 | 5972 | 0.060 |
Why?
|
Hemostatic Techniques | 1 | 2005 | 112 | 0.060 |
Why?
|
Calculi | 1 | 2024 | 48 | 0.060 |
Why?
|
Pancreatic Pseudocyst | 1 | 2024 | 110 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2013 | 2422 | 0.060 |
Why?
|
Administration, Rectal | 1 | 2023 | 70 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.060 |
Why?
|
Cholecystitis, Acute | 1 | 2024 | 75 | 0.060 |
Why?
|
Esophageal and Gastric Varices | 2 | 1996 | 208 | 0.060 |
Why?
|
Lithotripsy | 1 | 2024 | 140 | 0.050 |
Why?
|
Aspirin | 1 | 2015 | 3133 | 0.050 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2024 | 113 | 0.050 |
Why?
|
Nasal Mucosa | 2 | 2004 | 416 | 0.050 |
Why?
|
Foreign-Body Migration | 1 | 2005 | 219 | 0.050 |
Why?
|
Sweat | 1 | 2003 | 56 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 41487 | 0.050 |
Why?
|
Common Bile Duct | 1 | 2002 | 106 | 0.050 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2003 | 108 | 0.050 |
Why?
|
Pancreatic Ducts | 1 | 2024 | 329 | 0.050 |
Why?
|
Biliary Tract Neoplasms | 1 | 2024 | 185 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5840 | 0.050 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2002 | 120 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2014 | 4471 | 0.050 |
Why?
|
Cholecystitis | 1 | 2002 | 180 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3201 | 0.050 |
Why?
|
Angioplasty | 1 | 2024 | 355 | 0.050 |
Why?
|
Gastrostomy | 1 | 2024 | 323 | 0.050 |
Why?
|
Needles | 1 | 2024 | 451 | 0.050 |
Why?
|
Mutation | 3 | 2004 | 30052 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2024 | 2115 | 0.040 |
Why?
|
Crohn Disease | 1 | 2013 | 2279 | 0.040 |
Why?
|
Image Enhancement | 1 | 2010 | 2885 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14605 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 733 | 0.040 |
Why?
|
Budesonide | 2 | 2011 | 157 | 0.040 |
Why?
|
Dissection | 1 | 2021 | 298 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2024 | 952 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4124 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2023 | 947 | 0.040 |
Why?
|
Posture | 1 | 2023 | 957 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3415 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2024 | 1164 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2024 | 822 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2645 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9318 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1116 | 0.040 |
Why?
|
Clinical Enzyme Tests | 1 | 1998 | 113 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 748 | 0.040 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 605 | 0.040 |
Why?
|
Risk Assessment | 4 | 2024 | 23995 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 865 | 0.040 |
Why?
|
Biopsy | 2 | 2001 | 6766 | 0.040 |
Why?
|
Contrast Media | 1 | 2010 | 5311 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2024 | 860 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2244 | 0.030 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1996 | 64 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3728 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3673 | 0.030 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2373 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2024 | 1496 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 728 | 0.030 |
Why?
|
Gastric Bypass | 1 | 2024 | 818 | 0.030 |
Why?
|
Action Potentials | 1 | 2003 | 1834 | 0.030 |
Why?
|
Pralidoxime Compounds | 1 | 1995 | 5 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 1995 | 6 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1233 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 846 | 0.030 |
Why?
|
Fasciculation | 1 | 1995 | 9 | 0.030 |
Why?
|
Alkaline Phosphatase | 2 | 2011 | 864 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2024 | 2084 | 0.030 |
Why?
|
Chest Tubes | 1 | 1995 | 152 | 0.030 |
Why?
|
Atropine | 1 | 1995 | 244 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1118 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1995 | 185 | 0.030 |
Why?
|
Myxoma | 1 | 1995 | 114 | 0.030 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2024 | 1428 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 1998 | 0.030 |
Why?
|
Muscarinic Antagonists | 1 | 1995 | 135 | 0.030 |
Why?
|
Portal Vein | 1 | 1996 | 431 | 0.030 |
Why?
|
Quadriplegia | 1 | 1995 | 226 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1624 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
Ciliary Motility Disorders | 1 | 1993 | 51 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11076 | 0.030 |
Why?
|
Arteriovenous Malformations | 1 | 1995 | 396 | 0.030 |
Why?
|
Liver Diseases | 1 | 2001 | 1298 | 0.030 |
Why?
|
Family Practice | 1 | 2015 | 512 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 1972 | 0.020 |
Why?
|
Bronchiectasis | 1 | 1993 | 139 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1626 | 0.020 |
Why?
|
Hematocrit | 1 | 2013 | 623 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1995 | 362 | 0.020 |
Why?
|
Prevalence | 2 | 2009 | 15732 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2024 | 3049 | 0.020 |
Why?
|
Geriatrics | 1 | 2015 | 388 | 0.020 |
Why?
|
Administration, Oral | 2 | 2011 | 4021 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2011 | 523 | 0.020 |
Why?
|
Genetic Testing | 1 | 2003 | 3537 | 0.020 |
Why?
|
Sex Distribution | 1 | 1995 | 2281 | 0.020 |
Why?
|
Disease Progression | 1 | 2006 | 13506 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 1995 | 684 | 0.020 |
Why?
|
Fibrosis | 1 | 1996 | 2049 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 942 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6228 | 0.020 |
Why?
|
Age Distribution | 1 | 1995 | 2880 | 0.020 |
Why?
|
Dehydration | 1 | 2010 | 216 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 12990 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1379 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8224 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1995 | 1119 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2578 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2426 | 0.020 |
Why?
|
Genetic Variation | 1 | 2003 | 6567 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2016 | 1179 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1998 | 2691 | 0.020 |
Why?
|
Reference Values | 1 | 1995 | 4920 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10209 | 0.020 |
Why?
|
Heterozygote | 2 | 2004 | 2787 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20570 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2007 | 45 | 0.020 |
Why?
|
Spinal Cord | 1 | 1995 | 1818 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42230 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1870 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2024 | 15631 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1070 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1993 | 1010 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 659 | 0.020 |
Why?
|
Patients | 1 | 2012 | 907 | 0.020 |
Why?
|
Gastroscopy | 1 | 2007 | 211 | 0.020 |
Why?
|
Adolescent | 4 | 2016 | 88319 | 0.020 |
Why?
|
Phenotype | 1 | 2003 | 16591 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 22169 | 0.020 |
Why?
|
Steroids | 1 | 2010 | 929 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.020 |
Why?
|
Intestine, Small | 1 | 2011 | 1206 | 0.010 |
Why?
|
Isoproterenol | 1 | 2004 | 395 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3422 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 833 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36192 | 0.010 |
Why?
|
Malnutrition | 1 | 2010 | 645 | 0.010 |
Why?
|
Ion Transport | 1 | 2004 | 319 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3461 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3123 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 8529 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 256 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9646 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5492 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 578 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1256 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2008 | 1155 | 0.010 |
Why?
|
Stomach | 1 | 2007 | 696 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2007 | 1147 | 0.010 |
Why?
|
Young Adult | 3 | 2016 | 59243 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9326 | 0.010 |
Why?
|
Child | 3 | 2016 | 80153 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2161 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 1090 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3810 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1469 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7407 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168459 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2665 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1809 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4016 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81525 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1776 | 0.010 |
Why?
|
Sodium | 1 | 2004 | 1588 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3429 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12725 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3847 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1995 | 26198 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3415 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15601 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 1995 | 335 | 0.010 |
Why?
|
Rupture | 1 | 1995 | 443 | 0.010 |
Why?
|
Oligospermia | 1 | 1993 | 59 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9420 | 0.010 |
Why?
|
Diet | 1 | 2010 | 8075 | 0.010 |
Why?
|
Veins | 1 | 1995 | 768 | 0.010 |
Why?
|
Neck | 1 | 1995 | 734 | 0.010 |
Why?
|
Laparoscopy | 1 | 2001 | 2035 | 0.010 |
Why?
|
Heart Atria | 1 | 1995 | 1345 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2004 | 14414 | 0.000 |
Why?
|
Palliative Care | 1 | 2003 | 3598 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1995 | 1265 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1995 | 1027 | 0.000 |
Why?
|
Syndrome | 1 | 1993 | 3267 | 0.000 |
Why?
|
Hypertension, Pulmonary | 1 | 1995 | 1578 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1995 | 36426 | 0.000 |
Why?
|